London-based Royal Oak Health Ltd., a British company in the nutrition supplement and vitamin sector, has received the top honour at the Made in Britain Impact Awards.
The Heroes of British Award recognises Royal Oak Health’s achievement in expanding its global footprint, marking a record year for export growth across international markets.
Since launching its line of British-made premium products, Royal Oak Health has prioritised exports as a core growth strategy. By the end of 2022, the company reached £600,000 in export revenue, with a remarkable surge to £3.4 million in 2023. As of July 2024, export sales have already surpassed £3.5 million.
This rapid growth is attributed to strategic market penetration, particularly in Asia, where Royal Oak Health has tapped into increasing demand for high-quality supplements among health-conscious consumers. In addition to its success in Asia, the company is building on organic growth in the UK by expanding distribution channels and establishing retail partnerships. Plans for further expansion into European and North American markets are also underway, with launches slated for 2025 and beyond.
Royal Oak Health attributes its export success to a combination of skilled team development, strong international partnerships, and a commitment to quality, sustainability, and an understanding of local markets. Central to its export achievements is the company’s dedication to producing high-quality health products that cater to diverse international consumer needs while adhering to stringent manufacturing standards and regulatory requirements.
The company’s strategic focus on cultural sensitivity and sustainability has been instrumental in establishing Royal Oak Health as a trusted, forward-thinking brand in the global market.
Made in Britain is an internationally recognised registered trademark which promotes and acknowledges the very best of British manufacturing. The not-for-profit organisation brings together the British manufacturing community, united with the registered trademark.
A spokesperson from Made in Britain comments: “Royal Oak Health demonstrated hugely impressive export results, plus clear presentation of growth, approach and ambitions, across multiple markets.”
Martin Zahra, Executive Director of Royal Oak Health Ltd, comments: “Over the last three years, our growth has been fuelled by a strategic approach to team development, cultivating a multi-skilled sales workforce that can adapt to the dynamic demands of international markets. At the core of our success is an unwavering commitment to high-quality products, which has enabled us to build trust and loyalty across diverse regions. By combining this commitment to quality with a strengthened sales team and a dedicated export focus, we’ve developed a robust framework that not only sustains but accelerates our global growth, positioning us to thrive in the competitive international market.”
